Advertisement Insight Pharmaceuticals recalls nasal decongestant over bacterial contamination - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Insight Pharmaceuticals recalls nasal decongestant over bacterial contamination

Insight Pharmaceuticals has issued a voluntary recall of one lot of Nostrilla Nasal Decongestant nasal spray as it has the potential to be contaminated with bacteria Burkholderia cepacia.

Internal investigations revealed the presence of a microbial contaminant that exceeds the product specifications which may subsequently result in a subpar product.

The product bearing the UPC Code, 6373673005, was distributed in the US through retail outlets and pharmacies.

Burkholderia cepacia can cause serious infection in individuals with a weak immune system or chronic lung condition.

The company, however, said that no illnesses have been reported.